Changzhou Pharmaceutical Factory RX
FDA Approved Drugs
Changzhou Pharmaceutical Factory RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 16
- Latest Approval Date Oct 28, 2025
- Data Source FDA
- First Approval Date Oct 31, 2016
Company Overview
Company
Changzhou Pharmaceutical Factory RX
Country
China
Website
Social Profiles
Company Snapshot
Changzhou Pharmaceutical Factory RX
NO. 518 Laodong East Road, Changzhou, Jiangsu, 213018 China
China
www.czpharma.com/ shm@czpharma.com View on MapFDA Approved Drug Records ( 16 records )
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2019-10-07
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
209402
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2019-10-07
Regulatory Status
RX
Drug Name
DOXYCYCLINE HYCLATE
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2019-10-09
Active Ingredient
DOXYCYCLINE HYCLATE
Application Number
211343
Product Number
1
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2019-10-09
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
2
Dosage Form
-
Strength
75MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
2
Dosage Form
-
Strength
75MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
4
Dosage Form
-
Strength
150MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
4
Dosage Form
-
Strength
150MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
5
Dosage Form
-
Strength
200MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
6
Dosage Form
-
Strength
225MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
6
Dosage Form
-
Strength
225MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
7
Dosage Form
-
Strength
300MG
Approval Date
2021-07-15
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
7
Dosage Form
-
Strength
300MG
Approval Date
2021-07-15
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
8
Dosage Form
-
Strength
25MG
Approval Date
2024-09-26
Active Ingredient
PREGABALIN
Application Number
214322
Product Number
8
Dosage Form
-
Strength
25MG
Approval Date
2024-09-26
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2016-10-31
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207408
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2016-10-31
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2016-10-31
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207408
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2016-10-31
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2016-10-31
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207408
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2016-10-31
Regulatory Status
RX
Drug Name
ROSUVASTATIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2016-10-31
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207408
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2016-10-31
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Active Ingredient
TICAGRELOR
Application Number
216187
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2025-10-28
Regulatory Status
RX
Drug Name
TICAGRELOR
Product Number
2
Dosage Form
-
Strength
90MG
Approval Date
2025-10-28
Active Ingredient
TICAGRELOR
Application Number
216187
Product Number
2
Dosage Form
-
Strength
90MG
Approval Date
2025-10-28
Regulatory Status
RX
Drug Status Breakdown
16 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
DOXYCYCLINE HYCLATE
Application Number
209402
Product Number
1
Active Ingredient
DOXYCYCLINE HYCLATE
Dosage Form
-
Strength
EQ 100MG BASE
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.